This key CD4+ T cell help occurs through the licensing of dendritic cells (cDC1) through their interaction with MHC II and CD40/CD40L on CD4+ T cells, which was recently demonstrated in vivo in tumors (9), and resulted in successful cross presentation of tumor antigens to CD8+ T cells. Here, CD40 is linked to neoplasm.